Nuvation Bio Inc. (NUVB)
NYSE·Healthcare·Biotechnology
$4.50
-0.33%
Mkt Cap $1.60B
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (20 analysts)
$20.50
Range $20.00 – $21.00
Implied Upside
+356.1%
Consensus $20.50 vs current $4.50
NYSE·Healthcare·Biotechnology
$4.50
-0.33%
Mkt Cap $1.60B
Buy
9
Hold
0
Sell
0
Price Target (20 analysts)
$20.50
Range $20.00 – $21.00
+356.1%
Consensus $20.50 vs current $4.50